How AI is set to transform patient outcomes and surgical practices

A Ten­nessee fed­er­al judge on Wednes­day de­clined to dis­miss a trade se­crets law­suit against Re­vance Ther­a­peu­tics, which launched a Botox ri­val in 2022 and is

Carte­sian Ther­a­peu­tics, an mR­NA cell ther­a­py biotech, said its lead in­ves­ti­ga­tion­al med­i­cine helped pa­tients with an au­toim­mune con­di­tion that has caught the at­ten­tion of many